chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 12/23/2021 pt was found down in his home. Passed out from missed HD 2/2 acute COVID infection. Received moderna doses on 3/26/2021 & 4/30/2021.
I received my second vaccine uneventfully and approx. 2 1/2 days later I developed a painfully and swollen lower lip , and then it had severe erythema , pain and ulceration . I have never had a cold sore in my life, or shingles . I did receive the chicken pox vaccine in my 30's
Pt admitted on 4/23 with afib, tachycardia, and biventricular heart failure. On 4/29 he had a COVID test for SNF placement that was positive despite being asymptomatic.
Pt had a severe UTI infection for E coli after the second dose of PFIZER vaccine, on 9/30/2021 she had the booster vaccine and about 7 days later she started with UTI symptoms with a positive Urine culture for E. Coli.
08/05/21, 10:20AM,  called stating that she developed symptoms (headache, hoarseness) yesterday, came to work today, is going home now, her father who she lives with tested positive 08/03, father stated having symptoms on 08/01,  got tested negative on 08/02 before having symptoms.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021 at 9:09 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 31-Mar-2021 at 9:09 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    No concomitant medication was reported by reporter. Batch number 019B21A underwent temperature excursion on 31-Mar-2021 with temperature 32 degrees Fahrenheit at 08:00 AM. This vial was moved to fridge on 23-Mar-2021 and beyond use date for the vial was reported as 22-Apr-2021. Product moved to clinic on 31-Mar-2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic. It was reported that each time a vial was put into a cooler, sometimes there was a period of time of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35 degree Fahrenheit. Temperature recordings were taken by using a traceable temperature monitor at every hour. The vial was not in a frozen state at the time of vaccine administration. After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature. No treatment information was provided.
Child erroneously received 2nd dose of flu shot 1 week after 1st shot. There is a possibility that the first dose contained 0.5cc instead of 0.25cc. Child has not experienced any adverse reaction.
1/5/21 started with fever (up to 101), severe body aches, shaking from being cold even bundled with electric blanket, nausea and vomiting. That lasted through 1/8. On 1/7 I started having trouble with taking a deep breath. Chest would get very tight and hurt when I would take a big breath, bend forward, or lay back.  I went to express care and they could not rule out pericarditis. Told me to go to the Emergency Room for further work up to rule out spontaneous PE or pericarditis.
Fever (100.9 degrees fahrenheit), migraine, nausea, vomiting, fatigue, dizziness
HPV was given in error instead of Prevnar vaccine. Mom states child has had fever and upper respiratory symptoms since 2 days after vaccination.
Noticed 4 days after vaccine that he was chewing his tongue and clitching his teeth.  This lasted for 4 nights then stopped. He did a night guard due to this.
became very light headed, dizzy, nauseous, upper body very cold and tingly, headache and confused feelings, broke out in cold sweat....called 911...blood pressure 90/60 with faint pulse and slow heart rate..offered oxygen...did not transport to ER
6:00 pm starting getting mild chills and headache. Took ibuprofen. Felt better by this morning. Sore arm for a few days.
Elevated resting heart rate of 120 - 135 lasting 24 hours. Patient remained resting  during the full period
Patient presented with urticarial rash on chest, arms, and back.  Was given IV benadryl and IV solumedrol in ED and was discharged with PO benadryl.
This unsolicited case was received on 05 June 2015 from literature. Abstract: Although naturally occurring smallpox virus was officially declared eradicated in 1980, concern for biological warfare prompted the Government in 2002 to recommend smallpox vaccination for select individuals. Vaccinia, the smallpox vaccine virus, is administered into the skin, typically on the upper arm, where the virus remains viable and infectious until the scab falls off and the epidermis is fully intact - typically 2-4 weeks. Adverse events following smallpox vaccination may occur in the vaccinee, in individuals who have contact with the vaccinee (i.e., secondary transmission), or in individuals who have contact with the vaccinee's contact (i.e., tertiary transmission). In June 2014, two cases of inadvertent inoculation of vaccinia and one case of a non-viral reaction following vaccination occurred. This includes the first reported case of shaving as the likely source of autoinoculation after contact transmission. This paper describes the diagnosis and treatment of these cases, the outbreak investigation, and steps taken to prevent future transmission. A two male patients (age not reported), whose medical history and concomitant medication were not reported, had received a dose of ACAM2000 (lot number: VV04-003-A, manufacturer: Sanofi Pasteur Biologics Co.) on June 2014 (route was not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. On unspecified date in June 2014 post vaccination, patient experienced inadvertent inoculation of vaccinia. Patient's shaving was likely the source of autoinoculation after contact transmission. Laboratory investigation and corrective treatment were not reported. At the time of this report, outcome of the event was unknown. Upon internal review, the company assessed the event of autoinoculation after contact transmission as serious and medically significant. List of documents held by sender: none.
Found in crib unresponsive. Medical record received on 11/22/2004 states pt expereinced congestion. Autopsy Report received on 1/12/2005 states SIDS.
- Headache: starting about 12 hours after the vaccine and continuing for 2 days  - Fatigue: starting about 12 hours after the vaccine and continuing for about 2 days  - Chills: starting about 16 hours after the vaccine and intensifying until 24 hours after the vaccine administration  - Fever: starting about 16 hours after the vaccine and intensifying until 24 hours after the vaccine administration  - Blood clots: expulsion of clots during the same period as the fever and chills. Had completed menstruation 2 weeks prior, so not related to that.
Initial report received on 16 November 2006, from a consumer, the patient. A 30 year old female patient received on 13 November 2006, in the afternoon, Fluzone (lot number unknown) (unknown site, dose and route of administration). She had a sore throat that morning (13 November 2006), prior to vaccination. She continued to experience the sore throat after the vaccination. She also experienced after vaccination, cough, sneezing, sinus congestion and headache. At the time of the report, 16 November 2006, the signs and symptoms were still persisting and the patient had not recovered. No corrective treatment was reported. The patient did not receive any concomitant vaccines or medications. No information on prior exposure was reported.
Mom reports that the day after receiving vaccines, husband noted that child was blinking a lot.  This persisted for approximately 3-5 days. During this time, mother reports she gave child OTC alpha lipoic acid mixed in a drink.
Began having ever increasing visual /ocular migraines with very slight headache after first injection on February 1, 2021.  After second injection, March 1, 2021 began having very frequent visual migraines and light headaches and went to emergency room.  7 days later I had an occipital stroke and was hospitalized for several days.  I am slowly recovering.  Symptoms were only visual but quite severe for a short time.
Information has been received from a physician concerning her 29 year old daughter with no known allergies or pertinent medical history who one month ago (December 2007), was vaccinated with varicella virus vaccine live (Oka/Merck). There was no concomitant medication. After receiving the vaccine (December 2007), the patient developed what the physician was questioning as an injection site reaction. She indicated that there was redness and swelling around the area of administration, the patient was seen by a physician. No laboratory or diagnostic studies were performed. On an unspecified date, the patient had recovered.
The pt presented to the clinic for the moderna vaccine. The MA drew up the vaccine and administered the vaccine to the pt. Once the MA was documenting the vaccine, she received an error message stating the pt should not receive the vaccine.  I was notified at the end of the day. Contacted the CDC and was informed to have pt monitor for CP, SOB, or palpitations, and seek care at the nearest ER if he develops any symptoms.
Evening after injection spiked fever (subjective) & body aches. Local skin redness at (L) deltoid injection site approx 8cm, warm to touch. Mom states today that he did this a few years ago after Flu shot. Tx: TYLENOL, ice to site.
stress and anxiety; acid reflux; stress and anxiety; felt ill; This spontaneous case was reported by a consumer and describes the occurrence of STRESS (stress and anxiety), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux), ANXIETY (stress and anxiety) and MALAISE (felt ill) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A212) for COVID-19 vaccination.     Family history included Cardiac disorder (history of cardiac issues with her dad and uncle.) since an unknown date.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced STRESS (stress and anxiety), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux), ANXIETY (stress and anxiety) and MALAISE (felt ill). At the time of the report, STRESS (stress and anxiety), GASTROOESOPHAGEAL REFLUX DISEASE (acid reflux), ANXIETY (stress and anxiety) and MALAISE (felt ill) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided.  Acid reflux medication was given as treatment for acid reflux Around thanksgiving last year she got sick, but never had a laboratory COVID-19 test.   This case was linked to MOD-2021-370134 (Patient Link).
Side effects; This case was reported by a consumer via interactive digital media and described the occurrence of adverse event in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was not recovered/not resolved.   It was unknown if the reporter considered the adverse event to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as an adult as per the vaccine indication. The patient received Shingrix and had side effects. The reporter asked how long did the side effects last.
soreness in the arm after the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in the arm after the 1st dose) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness in the arm after the 1st dose). At the time of the report, PAIN IN EXTREMITY (soreness in the arm after the 1st dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient stated that her body usually reacts to things like that after she gets a flu shot and usually sits down for 30 minutes. No concomitant medications were provided by the reporter. No treatment medications were provided by the reporter.   This case was linked to MOD-2021-433896 (Patient Link).
According to mother, after receiving shot yesterday afternoon, child broke out in a red rash on face and legs and began to itch. Was treated at home with Vistaril. Denies any symptoms today, 10/30/2001. Also treated with Tagamet and Zyrtec. The 4 X that she received in the past without allergy or allergic reaction.
Redness,  swelling at the site,  lump size of a tennis ball, pain, edema, and hard to the  touch.  Received steroid injection.
Pt. has vaccine reaction to Dtap. Pt. parents did not notice of the vaccine reaction. Induration noted. Child c/o pain, full range of movement. No redness 3.5 cm x 3.0 cm induration.
Developed red, raised rash to arms, torso, back, legs @ approximately 7:00 pm 3-13-02.
her elbows came out; felt tired/ experienced chronic fatigue; achy all over; Fibromyalgia; More problems breathing; Problems with her intestines; This spontaneous case was reported by a consumer and describes the occurrence of FIBROMYALGIA (Fibromyalgia), DYSPNOEA (More problems breathing), GASTROINTESTINAL DISORDER (Problems with her intestines), FATIGUE (felt tired/ experienced chronic fatigue) and MYALGIA (achy all over) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Not Provided) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Immunocompromised and Asthma (, she had problems with her lungs (sister has asthma but after second dose experienced more problems breathing).   Sister also had problems with her intestines.  ).   In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. In January 2021, the patient experienced FIBROMYALGIA (Fibromyalgia), DYSPNOEA (More problems breathing) and GASTROINTESTINAL DISORDER (Problems with her intestines). On an unknown date, the patient experienced FATIGUE (felt tired/ experienced chronic fatigue), MYALGIA (achy all over) and JOINT DISLOCATION (her elbows came out). At the time of the report, FIBROMYALGIA (Fibromyalgia), DYSPNOEA (More problems breathing), GASTROINTESTINAL DISORDER (Problems with her intestines), FATIGUE (felt tired/ experienced chronic fatigue), MYALGIA (achy all over) and JOINT DISLOCATION (her elbows came out) outcome was unknown.            Sister was concerned about receiving full third dose and not half, as Moderna submitted FDA approval for 50 mcg dose now. she was worried that whether this dose will create any problem or not Concomitant medication use was unknown Treatment information was unknown   Reporter did not allow further contact
Patient called the following morning complaining of malaise, flu like symptoms and sore arm. She also reported low grade fever of 101. Encouraged her to take tylenolol or ibuprofen for fever and to monitor. Explained all sxs were normal side effects except the fever. 2 days post vaccination patients come in to the pharmacy fever free and feeling fine, but has a large rash around her lower abdomen and back. She explained she has hashimoto's and normally when she gets sicks she develops this rash. She also had just been on an airplane the morning she received the vaccine so she wasn't sure if maybe she was genuinely sick. Gave pt OTC Benadryl and hydrocortisone cream and told pt to monitor.
Arm swelling from elbow to shoulder, skin redness, itching and fluid-filled blisters at injection site.
Supraclavicular lymphadenopathy on vaccine side (left). Approximately 3cm painful lymph node swelling starting 1 day after vaccination and lasting 1 week total.
This is a spontaneous report from a 46 year old physician referring to himself and follow-up from his opthalmologist. In April, 1999, the pt received his 1st treatment with Lymerix at an unspecified dose. Sometime thereafter, he experienced arm soreness, which resolved. In May, 1999, he received he 2nd dose of Lymerix and sometime afterward he again had arm soreness and visual disturbances with floaters and shadows. Two ophthalmologists were consulted and he was dx'd with asteroid hyalosis, myopia, presbyopia and possible pars planitis. No treatment was given. The most recent information received on 7/29/1999, reports the outcome is good and the prognosis is good. The information received on 4/4/00 by the pt reported the symptoms are permanent and ongoing.
Late period; Spotting between periods; Increased PMS symptoms (severe nausea, cramps, fatigue, irritability); Increased PMS symptoms (severe nausea, cramps, fatigue, irritability); Increased PMS symptoms (severe nausea, cramps, fatigue, irritability); Increased PMS symptoms (severe nausea, cramps, fatigue, irritability); Increased PMS symptoms (severe nausea, cramps, fatigue, irritability); This is a spontaneous report from a non-contactable healthcare professional, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 01May2021 at 09:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not have medical history and allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included multivitamins (MANUFACTURER UNKNOWN) received within 2 weeks of vaccination and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0158) via an unspecified route of administration in the left arm on 10Apr2021 at 09:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. On 12Jun2021, the patient had late period, spotting between periods and increased PMS (Premenstrual syndrome) symptoms (severe nausea, cramps, fatigue, irritability). The events did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events late period, spotting between periods and increased PMS (Premenstrual syndrome) symptoms (severe nausea, cramps, fatigue, irritability) were unknown at the time of this report.  No follow-up attempts are possible. No further information is expected.
Developed several "rashy" areas on left chest and on left side of neck near ear.  Went to Urgent Care and was examined by PA.  I was informed that I had Shingles and was prescribed Valacyclovir, 1 gm and Gabapentin, 100 mg.
About 18 hours after vaccination, child was lethargic, low fever of 99.9, no appetite, complaining of abdominal pain. She vomited twice between 9:30am and 10:30am. She took a Tylenol dose of 10ml after second vomiting episode. Around 1pm her fever was gone and she was able to eat. She slowly recovered and was mostly back to normal by 5pm, with just pain at the injection site and some fatigue. I called the nurse practitioner at the clinic who had administered the shot. She said it sounded like an adverse reaction and to take her to urgent care. We were able to get a sick appointment with her pediatrician at 3pm that day who thought it might be that she had a separate virus.
Area of redness and mild rash at injection site - about 1 inch wide and 3 inches long.  Patient states area felt itchy. Denies systemic symptoms.
Interviewed pt on Thursday, 9/25/03 at 5pm per telephone. Pt states first three days following vaccinations felt weak, slow and slightly feverish. On the 13th day post-vaccination, pt states was not feeling well with neck and back pains, fever and chickenpox rash. Called local hospital and was directed to go to the ER, but states did not go right away. States temp was 102 degrees and was crying, delirious and seeing things happen. On the 15th day post vaccination, went to the ER. Darvocet, antibiotics, and antiviral medications were ordered for 10 days. Pt states flew for recovery period. Pt states 3 weeks later was back to the ER. States doctor stated her immune system was down. Antiviral medication was ordered along with Vicodin pain medication for muscle, lower neck and back pain and fever. States was dehydrated and received 2 liters of IV saline fluids. The pt was then referred to a physician. Temp continued to persist up to 103 deg. The pt states she was admitted on 9/5/03 and discharged the following Wednesday. States during this time received IV antibiotics, PIC line and IV antiviral medication. She was discharged on oral antiviral medication. The hospital discharge summary received on 2/19/04 states herpes simplex outbreak, urine retention, back pain and walking difficulty.
On March 29, 2022 my issues advanced as kind of a cold (runny nose, cough, etc.) And by Friday I had a fever of 102° and flu-like symptoms and needed to see someone about it. On 4/2/2022 I went to the walk-in clinic at Confluence Health. There I got a chest x-ray and a rapid COVID test(neg.) and possible Pneumonia was discovered from X-Ray. Treatment was as follows: Augmentin and Zithromax for a 10 day time. Currently still coughing but I am getting progressively better. No follow up scheduled. Addendum: Saw my PCP on 04/05/2022 and was given Tessalon pearl's, and am continuing to take Guaifenesin and Sudafed.